Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Net Cash Flow (2016 - 2026)

Healthequity has reported Net Cash Flow over the past 14 years, most recently at $9.7 million for Q1 2026.

  • Quarterly results put Net Cash Flow at $9.7 million for Q1 2026, up 136.88% from a year ago — trailing twelve months through Jan 2026 was $23.0 million (up 121.27% YoY), and the annual figure for FY2026 was $23.0 million, up 121.27%.
  • Net Cash Flow for Q1 2026 was $9.7 million at Healthequity, up from $4.8 million in the prior quarter.
  • Over the last five years, Net Cash Flow for HQY hit a ceiling of $75.7 million in Q3 2024 and a floor of -$423.7 million in Q1 2022.
  • Median Net Cash Flow over the past 5 years was $9.7 million (2026), compared with a mean of -$19.4 million.
  • Biggest five-year swings in Net Cash Flow: crashed 1538.91% in 2022 and later soared 313.73% in 2023.
  • Healthequity's Net Cash Flow stood at $33.3 million in 2022, then surged by 31.24% to $43.7 million in 2023, then crashed by 110.82% to -$4.7 million in 2024, then surged by 201.44% to $4.8 million in 2025, then soared by 101.5% to $9.7 million in 2026.
  • The last three reported values for Net Cash Flow were $9.7 million (Q1 2026), $4.8 million (Q4 2025), and $16.6 million (Q3 2025) per Business Quant data.